在喘中使用肺表面活性剂
Odalys Blanco1, Mercyleidi Díaz-Reyes1, Alexis Labrada2
1Grupo de Investigación Farmacéutica, Centro Nacional de Sanidad Agropecuaria (CENSA), San José de las Lajas, CP 32 700, Mayabeque, Cuba.
European journal of pharmacology
|August 15, 2025
概括
肺表面活性剂对于呼吸和喘管理至关重要. 功能障碍导致呼吸道收缩,但治疗性表面活性剂可以通过恢复功能和调节喘患者的免疫反应来提供好处.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统生理学 呼吸系统生理学
- 免疫学 免疫学 免疫学
背景情况:
- 肺表面活性剂保持气膜稳定性和气道通透性,这对于高效的气体交换至关重要.
- 表面活性剂功能障碍与严重的肺部疾病有关,并且在喘病原和恶化中发挥作用.
- 表面活性剂系统影响先天和适应性免疫反应,影响喘易感性和解决.
研究的目的:
- 审查和综合有关肺表面活性剂和喘之间关系的当前知识.
- 阐明肺表面活性剂在喘机制和表现中的作用.
- 探索外源表面活性剂作为喘治疗策略的潜力.
主要方法:
- 对实验证据和临床试验的文献综述.
- 分析表面活性剂在呼吸道动力学和免疫调节中的作用背后的机制.
- 关于在喘中给予外源表面活性剂的数据的综合.
主要成果:
- 表面活性剂功能障碍有助于气道收缩和喘恶化.
- 外源表面活性剂可以通过恢复表面活性和调节免疫反应,在喘中提供治疗益处.
- 有证据表明,表面活性剂在喘中起着双重作用:促进病理学和提供治疗潜力.
结论:
- 肺表面活性剂是呼吸系统健康的组成部分,并显著影响喘.
- 针对表面活性剂系统为新喘治疗提供了一个有希望的途径.
- 进一步的研究是有必要的,以优化外源表面活性剂的管理,喘管理.
更多相关视频
相关概念视频
Breathing
60.3K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
60.3K
Asthma: Pathogenesis and Management
586
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
586
Antiasthma Drugs: Leukotriene Modifiers
470
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
470
Pulmonary Cycle: Exhalation
1.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K


